Compare
Dentsply Sirona Inc. vs Envista Holdings Corp
| Latest fiscal year | Dentsply Sirona Inc. XRAY | Envista Holdings Corp NVST |
|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 |
| Revenue | $3.68B | $2.72B |
| Revenue growth (YoY) | -3.0% | +8.3% |
| Gross margin | 50.0% | 54.7% |
| Operating margin | -11.5% | 7.9% |
| Net margin | -16.3% | 1.7% |
| Net income | -$598.00M | $47.00M |
| EPS (Diluted) | -$3.00 | $0.28 |
| Operating cash flow | $235.00M | $275.70M |
| Free cash flow | $104.00M | $230.40M |
| Cash & equivalents | $326.00M | $1.21B |
| Total assets | $5.43B | $5.68B |
| Total liabilities | $4.09B | n/a |
| Shareholders' equity | $1.34B | $3.11B |
| Return on year-end equity | -44.6% | 1.5% |
| Shares outstanding | 199.60M | 163.80M |
Revenue, most recent five fiscal years
| Fiscal year | Dentsply Sirona Inc. | Envista Holdings Corp |
|---|---|---|
| Latest | $3.68B Ended 2025-12-31 | $2.72B Ended 2025-12-31 |
| 1 year earlier | $3.79B Ended 2024-12-31 | $2.51B Ended 2024-12-31 |
| 2 years earlier | $3.96B Ended 2023-12-31 | $2.57B Ended 2023-12-31 |
| 3 years earlier | $3.92B Ended 2022-12-31 | $2.57B Ended 2022-12-31 |
| 4 years earlier | $4.23B Ended 2021-12-31 | $2.51B Ended 2021-12-31 |